Results 41 to 50 of about 10,662,454 (348)

Role of the gut microbiota in hematologic cancer

open access: yesFrontiers in Microbiology, 2023
Hematologic neoplasms represent 6.5% of all cancers worldwide. They are characterized by the uncontrolled growth of hematopoietic and lymphoid cells and a decreased immune system efficacy.
P. Guevara-Ramírez   +5 more
semanticscholar   +1 more source

Patient‐reported physical well‐being predicts good long‐term survival of hematopoietic stem cell transplantation

open access: yesCancer Medicine
Aim This study aimed to explore the association between patient‐reported items at different time points after hematopoietic stem cell transplantation (HSCT) and long‐term survival. Methods We conducted a study with 144 allogeneic HSCT patients, following
Yin Lu   +11 more
doaj   +1 more source

BRAF inhibitor and hairy cell leukemia-related transient acantholytic dermatosis [PDF]

open access: yes, 2020
Grover disease (GD) is an acquired, nonfamilial, nonimmune mediated, transient or persistent acantholytic dermatosis. Herein, we present a 72-year-old man who had clinical and histopathologic findings of GD following two weeks of treatment with ...
Durkin, John R   +3 more
core  

Incidence and evaluation of incidental abnormal bone marrow signal on magnetic resonance imaging. [PDF]

open access: yes, 2014
PurposeThe increased use of magnetic resonance imaging (MRI) has resulted in reports of incidental abnormal bone marrow (BM) signal. Our goal was to determine the evaluation of an incidental abnormal BM signal on MRI and the prevalence of a subsequent ...
Cossor, Furha   +4 more
core   +3 more sources

Experience of Peripherally Inserted Central Venous Catheter in Patients with Hematologic Diseases

open access: yesInternal medicine, 2017
Objective Although use of the peripherally inserted central venous catheter (PICC) has become increasingly common, there are few reports of PICCs used for patients with hematologic diseases.
Yoshinori Hashimoto   +4 more
semanticscholar   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

The clinical characteristics and prognosis analysis of acute B-cell lymphoblastic leukemia with MEF2D fusions

open access: yesAnnals of Hematology
To investigate the clinical characteristics and prognosis of acute B-cell lymphoblastic leukemia (B-ALL) patients with MEF2D fusions. We retrospectively analyzed 15 newly diagnosed MEF2D-positive B-ALL patients admitted to The First Affiliated Hospital ...
Shuangzhu Liu   +9 more
doaj   +1 more source

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

open access: yesJournal of Hematology & Oncology, 2021
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for acute myeloid leukemia (AML). However, most patients experience relapse after allo-HSCT, with a poor prognosis, and treatment options are limited.
Qingya Cui   +16 more
doaj   +1 more source

Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. [PDF]

open access: yes, 2019
PURPOSE: To update the American Society of Clinical Oncology (ASCO)/American Society of Hematology (ASH) recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer.
Bohlius, Julia   +12 more
core   +3 more sources

Microbiota and Hematological Diseases

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2022
The microbiota is directly involved in the host metabolic process, as well as in immune response modulation and recruitment of different cells typology in the inflammatory site. Human microbiota modification (dysbiosis) is a condition which could be correlated with various pathologies.
openaire   +3 more sources

Home - About - Disclaimer - Privacy